Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A booster dose of SARS-COV-2 vaccine improves suboptimal seroconversion rates in patients with inflammatory bowel disease. Results of a prospective multicenter study of GETECCU (VACOVEII study).
Casas Deza D, Julián Gomara AB, Caudevilla Biota E, Beltrán B, Domènech E, Gutiérrez Casbas A, Mañosa M, Zabana Y, Roc Alfaro L, Valverde Romero E, García González E, Sicilia B, Laredo V, Alcalá Escriche MJ, Madero Velázquez L, Ferreiro-Iglesias R, Palmero Pérez A, Calafat M, Rubio Iturria S, Moraleja Yudego I, Ber Nieto Y, García Mateo S, P Gisbert J, Vicente Lidón R, Arias L, Alfambra E, Doñate Borao AB, Peña González E, Corsino Roche P, Vicuña Arregui M, Elorza A, Domínguez Cajal M, Chaparro M, Barreiro-de Acosta M, García-López S. Casas Deza D, et al. Among authors: zabana y. Gastroenterol Hepatol. 2023 Nov 23:S0210-5705(23)00474-0. doi: 10.1016/j.gastrohep.2023.11.004. Online ahead of print. Gastroenterol Hepatol. 2023. PMID: 38007154 English, Spanish.
European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.
Rahier JF, Ben-Horin S, Chowers Y, Conlon C, De Munter P, D'Haens G, Domènech E, Eliakim R, Eser A, Frater J, Gassull M, Giladi M, Kaser A, Lémann M, Moreels T, Moschen A, Pollok R, Reinisch W, Schunter M, Stange EF, Tilg H, Van Assche G, Viget N, Vucelic B, Walsh A, Weiss G, Yazdanpanah Y, Zabana Y, Travis SP, Colombel JF; European Crohn's and Colitis Organisation (ECCO). Rahier JF, et al. Among authors: zabana y. J Crohns Colitis. 2009 Jun;3(2):47-91. doi: 10.1016/j.crohns.2009.02.010. Epub 2009 Apr 26. J Crohns Colitis. 2009. PMID: 21172250 No abstract available.
Abdominal aortitis associated with Crohn's disease.
Domènech E, Garcia-Planella E, Olazábal A, Sánchez-Delgado J, Zabana Y, Bernal I, Mañosa M, Olivé A, Gassull MA. Domènech E, et al. Among authors: zabana y. Dig Dis Sci. 2005 Jun;50(6):1122-3. doi: 10.1007/s10620-005-2716-4. Dig Dis Sci. 2005. PMID: 15986866 No abstract available.
Pernicious anaemia in triplets. A case report and literature review.
Masnou H, Domènech E, Navarro-Llavat M, Zabana Y, Mañosa M, García-Planella E, Gassull MA. Masnou H, et al. Among authors: zabana y. Gastroenterol Hepatol. 2007 Dec;30(10):580-2. doi: 10.1157/13112591. Gastroenterol Hepatol. 2007. PMID: 18028852 Review.
Clinical outcome of newly diagnosed Crohn's disease: a comparative, retrospective study before and after infliximab availability.
Domènech E, Zabana Y, Garcia-Planella E, López San Román A, Nos P, Ginard D, Gordillo J, Martínez-Silva F, Beltrán B, Mañosa M, Cabré E, Gassull MA. Domènech E, et al. Among authors: zabana y. Aliment Pharmacol Ther. 2010 Jan 15;31(2):233-9. doi: 10.1111/j.1365-2036.2009.04170.x. Epub 2009 Oct 13. Aliment Pharmacol Ther. 2010. PMID: 19832727 Free article.
94 results